Back
CTNND1HGNC PubMedRecurrent variant

Germline whole-exome sequencing identifies CTNND1 as a candidate gene for hereditary gastric cancer in a large Brazilian cohort.

de Souza DC, Buranello T, Neto DTT, et al.Gastric Cancer 2026 · July 2026
Relevance score
4/10
Disease / domain
Hereditary gastric cancer
Source
PubMed
PMID 42446611
Share on LinkedIn

Gene / mechanism

Rare germline CTNND1 variant (a CDH1 partner); diffuse and signet-ring cell gastric tumours.

Summary

First Brazilian germline whole-exome sequencing study (126 patients) dedicated to hereditary gastric cancer predisposition. Among the 11 cases with an identified predisposition syndrome, BRCA2 was the most frequently mutated (27.3 %). Sequencing highlighted candidate genes, including FBXO24 and above all CTNND1, the latter with emerging evidence of association with gastric predisposition. TCGA somatic data showed that diffuse gastric tumours and signet-ring cell adenocarcinomas with CTNND1 mutations exhibited high microsatellite instability and high mutation count.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The biological link of CTNND1 (p120-catenin) with CDH1, the major hereditary diffuse gastric cancer gene, makes the hypothesis plausible. But this is a candidate gene supported by a single rare germline variant, without segregation or functional proof — hence a cautious score. Worth following, but not yet to be presented as a validated predisposition gene in clinic.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 1/3Evidence 2/3Novelty 1/2Sample 0/1Publication 0/1

Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 0/1 → Total: 4/10

Keywords

CTNND1gastric cancerCDH1candidate genegermline exome
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime